NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center

项目摘要/摘要 国家临床试验网络(NCTN)在UPMC Hillman的领先学术参与网站的目标 癌症中心，是为了提高我们在概念化、发展、激活、 NRG肿瘤学、ECOG-ACRIN的后期临床试验的性能和报告 肿瘤学网络小组临床试验联盟。这将通过提高质量来实现 我们的科学和行政领导地位；通过特别努力，增加NCTN试验的应计收入 针对少数民族、农村和其他特殊人群；改进我们的流程，以迅速激活新的 试验，特别是针对罕见癌症和基因定义的亚群的试验； 指导初级调查人员如何进行NCTN第二阶段和第三阶段试验，以及在行政管理方面， 在NCTN内晋升到领导职位所需的科学和人际交往技能以及 美国国家癌症研究所。

Project Summary/Abstract The goal of the National Clinical Trials Network (NCTN) Lead Academic Participating Site at UPMC Hillman Cancer Center, is to increase our level of participation in conceptualization, development, activation, performance, and reporting of the late-phase clinical trials of the NRG Oncology, ECOG-ACRIN, and Alliance for Clinical Trials in Oncology Network Groups. This will be accomplished by enhancing the quality of our scientific and administrative leadership; increasing accruals to NCTN trials, with special efforts directed at minority, rural and other special populations; improving our processes for rapid activation of new trials, with special efforts directed at trials for rare cancers and genotypically-defined subpopulations; and mentoring junior investigators in how to conduct phase 2 and phase 3 NCTN trials, and in the administrative, scientific, and interpersonal skills needed for advancing into positions of leadership within the NCTN and National Cancer Institute.